Article Figures & Data
Figures
- Figure 1.
Overall, progression-free, and distant metastasis-free survival curves for the patients in this study. Straight, dashed, and dotted lines indicate overall, progression-free, and distant metastasis-free survival, respectively.
- Figure 2.
Regional control and local progression-free rates. Straight and dotted lines indicate regional control and local progression-free rates, respectively.
- Figure 3.
Survival curves according to regional and local control. (a) Overall survival of the patients with regional control (straight line) vs. recurrence (dotted line). The 3-year rates in the control and recurrence groups were 70.3% and 53.9%, respectively (p=0.116). (b) Progression-free survival of the patients with regional control (straight line) vs. recurrence (dotted line). The 3-year rates in the control and recurrence groups were 64.6% and 15.4%, respectively (p<0.001). (c) Overall survival of the patients with local control (straight line) vs. recurrence (dotted line). The 3-year rates in the control and recurrence groups were 69.8% and 42.9%, respectively (p=0.047). (d) Progression-free survival of the patients with local control (straight line) vs. recurrence (dotted line). The 3-year rates in the control and recurrence groups were 53.6% and 14.3%, respectively (p=0.013).
- Figure 4.
Regional control according to treatment method. (a) Chemoradiotherapy (straight line) vs. radiotherapy alone (dotted line). (b) Proton beam therapy (straight line) vs. photon beam radiotherapy (dotted line).
